Back to Trades
Keller Eric L.
CHIEF EXECUTIVE OFFICERDirectorCIK 0002156365
Profile
- Filings
- 2
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 2 filings between 2026, Keller Eric L., CHIEF EXECUTIVE OFFICER, Director, has disclosed $3.2M in transactions — all concentrated in Retension Pharmaceuticals, Inc. (RTSN). Their disclosed trades are heavily weighted toward buying — $249.6K in buys and $0 in sells. The largest single open-market purchase on record is $249.6K in Retension Pharmaceuticals, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Oct 13 | RTSN Retension Pharmaceuticals, Inc. | Keller Eric L. | CHIEF EXECUTIVE OFFICER, Director | Buy | $249.6K |
| Oct 8 | RTSN Retension Pharmaceuticals, Inc. | Keller Eric L. | Chief Executive Officer, Director | Other | $0 |
2 filings